The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients
The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Sponsor: Sadat City University
This PHASE1/PHASE2 trial investigates Major Depressive Disorder and is currently completed. Sadat City University leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Recruiting → Completed
-
May 2020 — Jul 2020 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 2 earlier versions
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2019 — Apr 2020 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sadat City University
For direct contact, visit the study record on ClinicalTrials.gov .